|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Other Revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Research and development, net of reimbursements | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income: | |||||
| Interest income – net | |||||
| Total other income | |||||
| Net loss | |||||
| Net loss per common share – basic (in Dollars per share) | |||||
| Net loss per common share – diluted (in Dollars per share) | |||||
| Weighted average common shares outstanding – basic (in Shares) | |||||
| Weighted average common shares outstanding – diluted (in Shares) | |||||
Loading...